Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy

Emil R Kyvsgaard; Caroline Riley; Michael Roost Clausen; Mads Harsløf; Line Dam Heftdal; Carsten U Niemann; Kirsten Grønbaek; Martin Hutchings; Simon Husby

doi:10.1111/bjh.19156

Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy

Emil R Kyvsgaard, Caroline Riley, Michael Roost Clausen, Mads Harsløf, Line Dam Heftdal, Carsten U Niemann, Kirsten Grønbaek, Martin Hutchings, Simon Husby^*

^*Corresponding author af dette arbejde

4 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	British Journal of Haematology
Vol/bind	204
Udgave nummer	1
Sider (fra-til)	356-360
Antal sider	5
ISSN	0007-1048
DOI	https://doi.org/10.1111/bjh.19156
Status	Udgivet - jan. 2024

Adgang til dokumentet

10.1111/bjh.19156

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{b50e66164d984e5b903e1b43abf48559,

title = "Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy",

keywords = "Antibodies, Bispecific/therapeutic use, CD3 Complex, COVID-19, Humans, Lymphoma, B-Cell/therapy",

author = "Kyvsgaard, {Emil R} and Caroline Riley and Clausen, {Michael Roost} and Mads Harsl{\o}f and Heftdal, {Line Dam} and Niemann, {Carsten U} and Kirsten Gr{\o}nbaek and Martin Hutchings and Simon Husby",

note = "Fase1Rigshospitalet",

year = "2024",

month = jan,

doi = "10.1111/bjh.19156",

language = "English",

volume = "204",

pages = "356--360",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy

AU - Kyvsgaard, Emil R

AU - Riley, Caroline

AU - Clausen, Michael Roost

AU - Harsløf, Mads

AU - Heftdal, Line Dam

AU - Niemann, Carsten U

AU - Grønbaek, Kirsten

AU - Hutchings, Martin

AU - Husby, Simon

N1 - Fase1Rigshospitalet

PY - 2024/1

Y1 - 2024/1

KW - Antibodies, Bispecific/therapeutic use

KW - CD3 Complex

KW - COVID-19

KW - Humans

KW - Lymphoma, B-Cell/therapy

UR - http://www.scopus.com/inward/record.url?scp=85174072168&partnerID=8YFLogxK

U2 - 10.1111/bjh.19156

DO - 10.1111/bjh.19156

M3 - Letter

C2 - 37830381

SN - 0007-1048

VL - 204

SP - 356

EP - 360

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 1

ER -